[HTML][HTML] HIV subtype diversity worldwide

N Bbosa, P Kaleebu, D Ssemwanga - Current Opinion in HIV and …, 2019 - journals.lww.com
The dynamic change in HIV subtype distribution presents future challenges for diagnosis,
treatment and vaccine design and development. An increase in recombinant viruses suggests …

[PDF][PDF] Update on HIV-1 diversity in Africa: a decade in review

RW Lihana, D Ssemwanga, A Abimiku, N Ndembi - Aids Rev, 2012 - researchgate.net
Background: HIV-1 strains have diversified extensively through mutation and recombination
since their initial transmission to human beings many decades ago in Central Africa in the …

A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

…, D Park, D Baker, D Doolabh, D Ssemwanga… - Science, 2021 - science.org
The progression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

…, DA Rasmussen, D Baker, DJ Nokes, D Ssemwanga… - Science, 2022 - science.org
Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing
in Africa over the past year has led to a major increase in the number of sequences that have …

Update on HIV-1 acquired and transmitted drug resistance in Africa.

D Ssemwanga, RW Lihana, C Ugoji… - AIDS …, 2015 - search.ebscohost.com
The last ten years have witnessed a significant scale-up and access to antiretroviral therapy
in Africa, which has improved patient quality of life and survival. One major challenge …

[HTML][HTML] Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and …

…, MA Soares, VV Soriano, D Ssemwanga… - PLoS …, 2015 - journals.plos.org
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …

[HTML][HTML] Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples

…, J Serwanga, B Kikaire, D Ssemwanga… - International Journal of …, 2021 - Elsevier
Objectives There is a high demand for SARS-CoV-2 testing to identify COVID-19 cases.
Real-time, quantitative PCR (qRT-PCR) is the recommended diagnostic test but a number of …

[HTML][HTML] Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda

…, N Paton, A Rambaut, J Seeley, D Ssemwanga… - The Lancet …, 2020 - thelancet.com
Background International and global organisations advocate targeting interventions to areas
of high HIV prevalence (ie, hotspots). To better understand the potential benefits of geo-…

Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a …

D Ssemwanga, J Asio, C Watera… - Journal of …, 2020 - academic.oup.com
Objectives We implemented the WHO cross-sectional survey protocol to determine rates of
HIV viral load (VL) suppression (VLS), and weighted prevalence, predictors and patterns of …

[HTML][HTML] Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones

…, GH Learn, L Yue, E Ruzagira, D Ssemwanga… - Virology, 2013 - Elsevier
We report the molecular identification, cloning and initial biological characterization of 12 full-length
HIV-1 subtype A, D and A/D recombinant transmitted/founder (T/F) genomes. T/F …